BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8357626)

  • 1. [Clinicopathologic prognostic factors of laryngeal and pharyngeal tumors. III: Supraglottic carcinoma].
    Díaz Fernández C; Suárez Nieto C; Herrero Monge F; Llorente Pendas JL; Fernández Pello M; Núñez Batalla F
    Acta Otorrinolaringol Esp; 1993; 44(3):159-64. PubMed ID: 8357626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic prognostic factors in laryngeal pharyngolaryngeal tumors. II. Glottic carcinomas].
    Suárez Nieto C; Herrera Monge F; Díaz Fernández C; Alvarez Alvarez I; Sota Equizábal E; Llorente Pendás JL; Gómez Martínez J
    Acta Otorrinolaringol Esp; 1993; 44(2):77-83. PubMed ID: 8334011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic prognostic factors in laryngeal and pharyngolaryngeal tumors. I. Carcinoma of the pyriform sinus].
    Suárez Nieto C; Herrera Monge F; Díaz Fernández C; Pérez Vázquez P; García Sánchez E; Baldo Sierra C
    Acta Otorrinolaringol Esp; 1993; 44(1):25-30. PubMed ID: 8471281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degree of tumour differentiation as a prognostic factor in advanced laryngeal cancer.
    Geelen CP; Hordijk GJ; Ravasz LA; Terhaard CH
    Acta Otorhinolaryngol Belg; 1995; 49(1):1-4. PubMed ID: 7725912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].
    Zbären P
    Ther Umsch; 1998 Jul; 55(7):449-52. PubMed ID: 9702117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and spread of laryngeal and hypopharyngeal carcinoma with reflections on the effect of preoperative irradiation. 139 cases studied by whole organ serial sectioning.
    Olofsson J; van Nostrand AW
    Acta Otolaryngol Suppl; 1973; 308():1-84. PubMed ID: 4521065
    [No Abstract]   [Full Text] [Related]  

  • 8. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stomal recurrence post laryngectomy in University College Hospital, Ibadan.
    Onakoya PA; Nwaorgu OG; Kokong DD; Adeosun AA; Ayodele KJ
    Afr J Med Med Sci; 2004 Mar; 33(1):65-8. PubMed ID: 15490797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas.
    Barona de Guzmán R; Martorell MA; Basterra J; Armengot M; Alvarez-Valdés R; Garin L
    Laryngoscope; 1993 May; 103(5):538-40. PubMed ID: 8483372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nucleolar organizer regions in supraglottic carcinoma.
    Yamamoto Y; Itoh T; Saka T; Sakakura A; Takahashi H
    Auris Nasus Larynx; 1997; 24(1):85-90. PubMed ID: 9148733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Criteria influencing prognosis in patients suffering from advanced squamous cell carcinoma of the oropharynx and supraglottis].
    Motsch C
    Laryngorhinootologie; 2002 Nov; 81(11):820-1. PubMed ID: 12458468
    [No Abstract]   [Full Text] [Related]  

  • 16. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
    Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of surgical margins in advanced laryngeal squamous carcinoma.
    Bradford CR; Wolf GT; Fisher SG; McClatchey KD
    Head Neck; 1996; 18(1):11-6. PubMed ID: 8774917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of pre-epiglottic space invasion in supracricoid partial laryngectomy with cricohyoidopexy.
    Suoglu Y; Guven M; Kiyak E; Enoz M
    J Laryngol Otol; 2008 Jun; 122(6):623-7. PubMed ID: 17888196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.